Back to search

Article

Pseudogene KRT17P3 Drives Cisplatin Resistance of Human NSCLC Cells by Modulating miR-497-5p/mTOR

2020-06-15

Abstract excerpt

<h4>Background: </h4> Chemoresistance is a major obstacle in non-small-cell lung cancer (NSCLC) treatment. The pseudogene KRT17P3 has been shown to be up-regulated in lung cancer tissues from patients with cisplatin resistance. However, its molecular mechanism in promoting chemoresistance has not been elucidated. <h4>Methods: </h4>: Real-time PCR was performed to evaluate KRT17P3 levels in plasma samples collected...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f035fe09-bb90-55d9-bdec-859f11a99a40
DOI
10.21203/rs.3.rs-34675/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pseudogene KRT17P3 Drives Cisplatin Resistance of Human NSCLC Cells by Modulating miR-497-5p/mTORDOI 10.21203/rs.3.rs-34675/v1
Select a neighboring publication to make it the new centre.